weight loss drug news today glp-1 The current range of weight-loss drugs on the market targets receptors. Seeking a new generation of weight-loss drugs, some companies are developing amylin analogs. Read more at the link in our The next generation of GLP-1
Description
Bottom line Berberine has been studied
However, patients also taking insulin or sulfonylureas should monitor blood glucose carefully, as reduced carbohydrate intake may necessitate medication adjustments to prevent hypoglycaemia
The combined activation might trigger metabolic changes that neither hormone produces alone
Bias AA, Hiday RA, Kline MM
Experts believe that as the popularity of Ozempic and other GLP-1 agonists continues to grow, so will the number of people who report adverse gastrointestinal events such as gastroparesis
doi: 10.2337/db18-1123 17 ChristensenMVedtofteLHolstJJVilsbllTKnopFK
